Meta-Analysis
Copyright ©The Author(s) 2023.
World J Crit Care Med. Dec 9, 2023; 12(5): 264-285
Published online Dec 9, 2023. doi: 10.5492/wjccm.v12.i5.264
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Study selection.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Human immunodeficiency virus seroprevalence among pregnant African women according to United Nation regions from 1984 to 2020.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Map of the distribution seroprevalence data among pregnant women in Africa. A: Human immunodeficiency virus; B: Human immunodeficiency virus-1; C: Human immunodeficiency virus-2. The base map was taken from (https://www.naturalearthdata.com/) and modified with Qgis software. HIV: Human immunodeficiency virus.
  • Citation: Ebogo-Belobo JT, Kenmoe S, Mbongue Mikangue CA, Tchatchouang S, Robertine LF, Takuissu GR, Ndzie Ondigui JL, Bowo-Ngandji A, Kenfack-Momo R, Kengne-Ndé C, Mbaga DS, Menkem EZ, Kame-Ngasse GI, Magoudjou-Pekam JN, Kenfack-Zanguim J, Esemu SN, Tagnouokam-Ngoupo PA, Ndip L, Njouom R. Systematic review and meta-analysis of seroprevalence of human immunodeficiency virus serological markers among pregnant women in Africa, 1984-2020. World J Crit Care Med 2023; 12(5): 264-285
  • URL: https://www.wjgnet.com/2220-3141/full/v12/i5/264.htm
  • DOI: https://dx.doi.org/10.5492/wjccm.v12.i5.264